Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wong

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
Journal of Neurology|December 14, 2022
Genotype-phenotype characterisation of long survivors with motor neuron disease in ScotlandDanielle J Leighton, Morad Ansari, Judith Newton, et al.
American Heart Journal|October 7, 2021
Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA studyDavid Chieng, Hariharan Sugumar, Liang-Han Ling, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Heart, Lung & Circulation|May 27, 2020
Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia During the COVID-19 Pandemic: A Living DocumentSaurabh Kumar, Haris Haqqani, Gareth Wynn, et al.
JAMA|January 10, 2023
Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical TrialPeter M Kistler, David Chieng, Hariharan Sugumar, et al.
Signal Transduction and Targeted Therapy|January 12, 2025
A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancerZhiwei Chen, Jianhua Chen, Dingzhi Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Plos Genetics|July 23, 2013
ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in miceLois Kelsey, Ann M Flenniken, Dawei Qu, et al.
Pediatric Neurology|October 8, 2025
Neurodevelopmental Outcomes From the PREVeNT TrialSarah E O'Kelley, Jamie K Capal, Tarrant O McPherson, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Journal of Neurology|December 14, 2022
Genotype-phenotype characterisation of long survivors with motor neuron disease in ScotlandDanielle J Leighton, Morad Ansari, Judith Newton, et al.
American Heart Journal|October 7, 2021
Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA studyDavid Chieng, Hariharan Sugumar, Liang-Han Ling, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Heart, Lung & Circulation|May 27, 2020
Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia During the COVID-19 Pandemic: A Living DocumentSaurabh Kumar, Haris Haqqani, Gareth Wynn, et al.
JAMA|January 10, 2023
Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical TrialPeter M Kistler, David Chieng, Hariharan Sugumar, et al.
Signal Transduction and Targeted Therapy|January 12, 2025
A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancerZhiwei Chen, Jianhua Chen, Dingzhi Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Plos Genetics|July 23, 2013
ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in miceLois Kelsey, Ann M Flenniken, Dawei Qu, et al.
Pediatric Neurology|October 8, 2025
Neurodevelopmental Outcomes From the PREVeNT TrialSarah E O'Kelley, Jamie K Capal, Tarrant O McPherson, et al.
Pageof 35